Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio.
Source link
Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock
Date:
More like thisRelated
The Netherlands is bracing for potentially devastating US sanctions against the ICC
The Netherlands is bracing for potentially devastating US sanctions...
Why Stellantis Is Stopping Dealers From Advertising Rock-Bottom Prices
Plus, what’s the endgame for social-media marketing after undisclosed...
The Netherlands is bracing for potentially devastating US sanctions against the ICC
THE HAGUE, Netherlands -- The Netherlands is preparing for...